SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-14-403556
Filing Date
2014-11-07
Accepted
2014-11-07 16:49:23
Documents
12
Period of Report
2014-09-30
Filing Date Changed
2014-11-07

Document Format Files

Seq Description Document Type Size
1 10-Q d799226d10q.htm 10-Q 478537
2 EX-10.1 d799226dex101.htm EX-10.1 8982
3 EX-31.1 d799226dex311.htm EX-31.1 9132
4 EX-31.2 d799226dex312.htm EX-31.2 9111
5 EX-32.1 d799226dex321.htm EX-32.1 4048
6 EX-32.2 d799226dex322.htm EX-32.2 4027
  Complete submission text file 0001193125-14-403556.txt   2609572

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cort-20140930.xml EX-101.INS 266097
8 XBRL TAXONOMY EXTENSION SCHEMA cort-20140930.xsd EX-101.SCH 24263
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20140930_cal.xml EX-101.CAL 40336
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20140930_def.xml EX-101.DEF 144911
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20140930_lab.xml EX-101.LAB 202551
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20140930_pre.xml EX-101.PRE 170236
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 141205506
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1